Capula Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Capula Management's PFE Position: Q1 2026 in Review
Capula Management reduced its Pfizer (PFE) stake by 86% in Q1 2026, selling an estimated $148K and leaving 929 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.
Capula Management first reported a position in PFE in Q1 2020 and has held it in 17 quarters since. The position peaked at $9.97M in Q2 2020. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Capula Management held 929 shares of Pfizer worth $26.1K as of Q1 2026.
- Capula Management sold 5,543 Pfizer shares in Q1 2026, an estimated $148K.
- Pfizer made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1030 holding.
- Capula Management first reported a position in Pfizer in Q1 2020 and has held it in 17 quarters since.
- Capula Management's Pfizer position peaked at $9.97M in Q2 2020.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.